Shuhei Otani

Title: The Innovations of Shuhei Otani

Introduction

Shuhei Otani is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that interact with specific receptors in the body. His work is characterized by a focus on innovative drug substances that have the potential to improve health outcomes.

Latest Patents

Shuhei Otani holds a patent for a compound titled "Salt and crystal form of compound having agonistic activity to S1P5 receptor." This compound, referred to as Compound I, exhibits high S1P receptor-selective agonist activity. The patent also covers the crystal forms of Compound I, the salts of Compound I, and the crystal forms of salts thereof, which are provided as drug substances for pharmaceuticals. He has 1 patent to his name.

Career Highlights

Otani is currently employed at Ono Pharmaceutical Co., Ltd., a company known for its commitment to advancing medical science through innovative research and development. His work at Ono Pharmaceutical has allowed him to focus on the synthesis and application of novel compounds that can lead to new therapeutic options.

Collaborations

Throughout his career, Shuhei Otani has collaborated with talented colleagues, including Takayuki Fujito and Naoko Imura. These collaborations have fostered a productive environment for innovation and have contributed to the success of their projects.

Conclusion

Shuhei Otani's contributions to the field of pharmaceuticals through his innovative patent work exemplify the impact of dedicated inventors in advancing medical science. His ongoing efforts at Ono Pharmaceutical Co., Ltd. continue to pave the way for future breakthroughs in drug development.